Screen Readers Skip to Content

Gender-Affirming Hormones Improve Transgender and Nonbinary Youth Mental Health

Author: Ann & Robert H. Lurie Children's Hospital of Chicago
Author Contact: luriechildrens.org
Published: 21st Jan 2023
Peer-Reviewed Publication: Yes
Additional References: Transgender News Publications

Summary: Evidence from largest study in the United States on the impact of gender-affirming hormones, with longest follow-up.

Definition

Gender-affirming Hormones

Transgender hormone therapy, also called hormone replacement therapy (HRT) or gender-affirming hormone therapy (GAHT), is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for more closely aligning their secondary sexual characteristics with their gender identity. This form of hormone therapy is given as one of two types, based on whether the goal of treatment is masculinization or feminization:

  • Feminizing hormone therapy - for transgender women or transfeminine people; consists of estrogens and antiandrogens.
  • Masculinizing hormone therapy - for transgender men or transmasculine people; consists of androgens and antiestrogens.

Many international guidelines and institutions require persistent, well-documented gender dysphoria as a pre-requisite to starting gender-affirmation therapy.

Main Document

Transgender and nonbinary youth experienced significant improvement in appearance congruence (or the degree to which physical characteristics align with gender) and sustained improvements in depression and anxiety over two years after starting treatment with gender-affirming hormones, according to a multicenter U.S. study funded by the National Institutes of Health (NIH) and published in the New England Journal of Medicine.

"Our results provide robust scientific evidence that improved appearance congruence secondary to hormone treatment is strongly linked to better mental health outcomes in transgender and nonbinary youth," said lead author Diane Chen, PhD, pediatric psychologist with the Gender and Sex Development Program at Ann & Robert H. Lurie Children's Hospital of Chicago and Associate Professor at Northwestern University Feinberg School of Medicine. "This is critical, given that transgender youth experience more depression and anxiety, and are at a higher risk for suicidality than cisgender youth."

Many transgender or non-binary teens experience gender dysphoria, or the persistent distress caused by the discrepancy between their gender identity and physical appearance. Gender-affirming hormones (testosterone or estradiol) are used as treatment to foster gender-congruent secondary sex characteristics, such as breast development or facial hair.

"The critical results we report demonstrate the positive psychological impact of gender-affirming hormones for treatment of youth with gender dysphoria," said senior author Johanna Olson-Kennedy, MD, Medical Director of the Center for Transyouth Health and Development at Children's Hospital Los Angeles. "Amidst a landscape of misinformation, we hope these findings support the use of timely and appropriate medical interventions for this vulnerable group of adolescents."

All the centers participating in the study employ a multidisciplinary team, comprising medical and mental health providers, that collaboratively determines whether gender dysphoria is present and gender-affirming medical care is appropriate. For minors, parental consent is required to initiate medical treatment.

"The positive findings of this observational study match the lived clinical experience of mental health experts who, in their many years of providing gender-affirming care, have repeatedly learned from the youth themselves about their mental health," said co-author Diane Ehrensaft, PhD, Director of Mental Health at the UC San Francisco Child and Adolescent Gender Center, and Professor of Pediatrics. "As the longitudinal study proceeds, we look forward to learning more from this cohort of patients - all of whom were screened carefully before beginning gender-affirming hormone treatment - about their journey going forward."

The study, the largest of its kind in the U.S., included 315 transgender and non-binary youth ages 12-20 years. Study visits occurred every six months for two years after treatment initiation, which is the longest follow-up reported to date. Researchers examined measures of appearance congruence, depression, anxiety, positive affect and life satisfaction.

They found that overall, appearance congruence, positive affect, and life satisfaction increased, while depression and anxiety symptoms decreased. Appearance congruence was associated with each psychosocial outcome assessed at baseline and during the follow-up period.

"Our results provide a strong scientific basis that gender-affirming care is crucial for the psychological well-being of our patients," said co-author Robert Garofalo, MD, MPH, Principal Investigator for the study at Lurie Children's, Co-Director of Lurie Children's Gender and Sex Development Program and Professor of Pediatrics at Northwestern University Feinberg School of Medicine. "We must ensure that access to this care remains available to youth with gender dysphoria."

This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD082554).

References and Source(s):

Gender-Affirming Hormones Improve Transgender and Nonbinary Youth Mental Health | Ann & Robert H. Lurie Children's Hospital of Chicago (luriechildrens.org). SexualDiversity.org makes no warranties or representations in connection therewith. Content may have been edited for style, clarity or length.

Post to Twitter Add to Facebook

Latest Transgender News Publications

The above information is from our reference library of resources relating to Transgender News that includes:


Evidence from largest study in the United States on the impact of gender-affirming hormones, with longest follow-up.
Publish Date: 21st Jan 2023

A study finds those who had gender-affirming therapies were less likely to have sleep disorders, suggesting a possible protective effect.
Publish Date: 21st Nov 2022 - Updated: 5th Jan 2023

Anti-science rule threatens to harm transgender and gender-diverse minors; sets a dangerous precedent for all health care decisions.
Publish Date: 5th Nov 2022

Study suggests 98% of adolescents with gender dysphoria who initiated gender-affirming hormone treatment as adolescents continued use at follow-up.
Publish Date: 21st Oct 2022


1LGBTQ+ Awareness and Events
LGBTQ+ awareness dates and events.

2Transgender Reporting Guide
How to write about transgender people.

3Glossary of Sexuality Terms
Definitions of sexual terms & acronyms.

4Glossary of Gender Terms
Definitions of gender related terms.

5Am I Gay? Questions to Ask
Think you may be gay or bisexual?

• Submissions: Send us your coming events and LGBTQ related news stories.


• Report Errors: Please report outdated or inaccurate information to us.



• (APA): Ann & Robert H. Lurie Children's Hospital of Chicago. (2023, January 21). Gender-Affirming Hormones Improve Transgender and Nonbinary Youth Mental Health. SexualDiversity.org. Retrieved January 30, 2023 from www.sexualdiversity.org/news/transgender/1132.php


• Permalink: <a href="https://www.sexualdiversity.org/news/transgender/1132.php">Gender-Affirming Hormones Improve Transgender and Nonbinary Youth Mental Health</a>